A phase II trial of CAP (Cyclophosphamide, Adriamycin, and Cisplatin) combination chemotherapy with radiotherapy for locally advanced non-small cell lung cancer

J. Kim, S. K. Kim, W. Y. Lee, K. Kim, Y. J. Park, J. Chang, E. H. Koh, C. M. Ahn, S. H. Oh, H. Y. Sohn, J. K. Roh, B. K. Cho, S. N. Hong, P. W. Hong, K. O. Choe, K. K. Lee, J. S. Seong, C. O. Suh, G. E. Kim

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase II trial of CAP (Cyclophosphamide, Adriamycin, and Cisplatin) combination chemotherapy with radiotherapy for locally advanced non-small cell lung cancer'. Together they form a unique fingerprint.